sulfasalazine has been researched along with Endometrial Neoplasms in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the role of ferroptosis in endometrial cancer treatment remains to be discussed." | 1.91 | Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. ( Hayashi, M; Murakami, H; Ohmichi, M; Terada, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, H | 1 |
| Hayashi, M | 1 |
| Terada, S | 1 |
| Ohmichi, M | 1 |
1 other study available for sulfasalazine and Endometrial Neoplasms
| Article | Year |
|---|---|
Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers.
Topics: Endometrial Neoplasms; Female; Ferroptosis; Humans; Medroxyprogesterone Acetate; Reactive Oxygen Spe | 2023 |